Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Brain and brain tumor uptake of L-3-(123I)iodo-alpha-methyl tyrosine: competition with natural L-amino acids

Journal Article · · Journal of Nuclear Medicine; (United States)
OSTI ID:5594452

SPECT studies with L-3-(123I)iodo-alpha-methyl tyrosine (IMT) were carried out in 10 patients with different types of brain tumors--first under fasting conditions (basal) and a week later during intravenous infusion of a mixture of naturally-occurring L-amino acids (AA load). An uptake index (UI) was calculated by dividing tissue count rates by the integral of plasma count rates. The UI decreased by 45.6% {plus minus} 15.4% (n = 10, p less than 0.001) for normal brain and by 53.2% {plus minus} 14.1% for gliomas (n = 5, p less than 0.01) during AA load compared to basal conditions, while two meningiomas and a metastasis showed only a minor decrease (23.9 {plus minus} 5.7%, n.s.). Two pituitary adenomas could not be delineated on the SPECT scans. These data indicate that IMT competes with naturally-occurring L-amino acids for transport into normal brain and gliomas. Transport characteristics of IMT into tumors of nonglial origin appear to be different from those of gliomas. For both types of tumors, it is advisable to perform IMT-SPECT under fasting conditions.

OSTI ID:
5594452
Journal Information:
Journal of Nuclear Medicine; (United States), Journal Name: Journal of Nuclear Medicine; (United States) Vol. 32:6; ISSN 0161-5505; ISSN JNMEA
Country of Publication:
United States
Language:
English